Загрузка...
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
AIM: To evaluate the outcomes in biological treatment and quality of life of psoriatic patients with chronic hepatitis C (CHC) treated with new Direct-Acting Antiviral agents (DAAs) compared to pegylated interferon-2α plus ribavirin (P/R) therapy. METHODS: This is a retrospective study involving pso...
Сохранить в:
| Опубликовано в: : | World J Hepatol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5838451/ https://ncbi.nlm.nih.gov/pubmed/29527268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i2.329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|